Canada Biotechnology & Medical Research

Medicure Inc (MPH)

Track

Track

Medicure Inc. experienced notable insider trading activity recently, with Director Albert David Friesen executing five purchase transactions totaling 26,595 CAD. These acquisitions occurred following the May 2026 results financiers, contributing to a 14.4% stock price increase over the past quarter. No selling activity was recorded during this period.
Ticker: MPH Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Medicure Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
105.59
Quantity 31,898 -17.6%
Value CA$476,456
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
11.84
Quantity 25,525 +19.2%
Value CA$3,520,723
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
355.69
Quantity 16,264 -6.5%
Value CA$447,015
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.22
Quantity 2,000 +0.4%
Value CA$2,440
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.20
Quantity 16,300 +3.0%
Value CA$19,560
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.05
Quantity 10,000 +1.9%
Value CA$10,500
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.05
Quantity 10,000 +1.9%
Value CA$10,500
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.30
Quantity 3,900 +0.8%
Value CA$5,070
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.30
Quantity 100 +0.0%
Value CA$130
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.30
Quantity 1,000 +0.2%
Value CA$1,300
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.25
Quantity 1,000 +0.2%
Value CA$1,250
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.30
Quantity 5,000 +1.0%
Value CA$6,500
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.25
Quantity 5,000 +1.0%
Value CA$6,250
2.2
Owens, Neil Wayne Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.12
Quantity 4,400 +220.0%
Value CA$4,928
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.05
Quantity 6,700 +1.4%
Value CA$7,035
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.99
Quantity 15,300 +3.2%
Value CA$15,147
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.00
Quantity 44,700 +10.4%
Value CA$44,700
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.05
Quantity 100 +0.0%
Value CA$105
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.05
Quantity 3,200 +0.7%
Value CA$3,360
3.6
Friesen, Albert David Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.10
Quantity 9,800 +2.3%
Value CA$10,780
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-06-22 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
31,898 -17.6%
105.59
CA$476,456 		31,898 -17.6% 105.59 CA$476,456
2026-06-23 2026-06-22 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
25,525 +19.2%
11.84
CA$3,520,723 		25,525 +19.2% 11.84 CA$3,520,723
2026-06-23 2026-06-22 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
16,264 -6.5%
355.69
CA$447,015 		16,264 -6.5% 355.69 CA$447,015
2026-06-22 2026-06-19 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
2,000 +0.4%
1.22
CA$2,440 		2,000 +0.4% 1.22 CA$2,440
2026-06-22 2026-06-19 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
16,300 +3.0%
1.20
CA$19,560 		16,300 +3.0% 1.20 CA$19,560
2024-06-03 2024-06-03 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
10,000 +1.9%
1.05
CA$10,500 		10,000 +1.9% 1.05 CA$10,500
2024-06-03 2024-05-31 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
10,000 +1.9%
1.05
CA$10,500 		10,000 +1.9% 1.05 CA$10,500
2023-04-28 2023-04-27 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
3,900 +0.8%
1.30
CA$5,070 		3,900 +0.8% 1.30 CA$5,070
2023-04-28 2023-04-21 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
100 +0.0%
1.30
CA$130 		100 +0.0% 1.30 CA$130
2023-04-21 2023-04-20 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
1,000 +0.2%
1.30
CA$1,300 		1,000 +0.2% 1.30 CA$1,300
2023-04-17 2023-04-14 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
1,000 +0.2%
1.25
CA$1,250 		1,000 +0.2% 1.25 CA$1,250
2023-04-14 2023-04-13 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
5,000 +1.0%
1.30
CA$6,500 		5,000 +1.0% 1.30 CA$6,500
2023-04-14 2023-04-13 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
5,000 +1.0%
1.25
CA$6,250 		5,000 +1.0% 1.25 CA$6,250
2023-01-09 2023-01-06 B Purchase
2.2
Owens, Neil Wayne

Senior Officer of Issuer

Officer
4,400 +220.0%
1.12
CA$4,928 		4,400 +220.0% 1.12 CA$4,928
2022-12-19 2022-12-16 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
6,700 +1.4%
1.05
CA$7,035 		6,700 +1.4% 1.05 CA$7,035
2022-12-19 2022-12-16 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
15,300 +3.2%
0.99
CA$15,147 		15,300 +3.2% 0.99 CA$15,147
2022-12-19 2022-12-16 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
44,700 +10.4%
1.00
CA$44,700 		44,700 +10.4% 1.00 CA$44,700
2022-12-12 2022-12-08 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
100 +0.0%
1.05
CA$105 		100 +0.0% 1.05 CA$105
2022-12-08 2022-12-06 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
3,200 +0.7%
1.05
CA$3,360 		3,200 +0.7% 1.05 CA$3,360
2022-12-08 2022-12-05 B Purchase
3.6
Friesen, Albert David

Director of Issuer, Senior Officer of Issuer

Executive Director
9,800 +2.3%
1.10
CA$10,780 		9,800 +2.3% 1.10 CA$10,780
Explore more

More insider trading research around Medicure Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America